de Amorim, R. P. [., Barbosa, M. M. C. [., Cassiano, D. P., Esposito, A. C. C., Dias, M. O. [., de Abreu, A. F. T. [., . . . Miot, H. A. [. (2024). Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: A randomized, double-blind, controlled clinical trial.
Chicago Style Citationde Amorim, Rebecca P. [UNESP], Mayla M. C. [UNESP] Barbosa, Daniel P. Cassiano, Ana C. C. Esposito, Marina O. [UNESP] Dias, Ana F. T. [UNESP] de Abreu, Ediléia Bagatin, and Hélio A. [UNESP] Miot. Sequential Therapy With Topical Clobetasol for 14 Days Followed By Hydroquinone Versus Hydroquinone Alone in Facial Melasma Treatment: A Randomized, Double-blind, Controlled Clinical Trial. 2024.
MLA Citationde Amorim, Rebecca P. [UNESP], et al. Sequential Therapy With Topical Clobetasol for 14 Days Followed By Hydroquinone Versus Hydroquinone Alone in Facial Melasma Treatment: A Randomized, Double-blind, Controlled Clinical Trial. 2024.